Mata Nathan L.'s Form 4 filing
Belite Bio, Inc (BLTE) · filed Apr 21, 2026
- Accession no.
- 0001193125-26-167281
- Filed
- Apr 21, 2026
- Trade date
- Apr 20, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions. Open-market sales total $163.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mata Nathan L.CIK 0002013987 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | American depositary share | SSaleDisposed | −284 | $162.76F3 | −$46,223.84 | 13,382 | Direct | |
| Apr 20, 2026 | American depositary share | SSaleDisposed | −524 | $163.52F4 | −$85,684.48 | 12,858 | Direct | |
| Apr 20, 2026 | American depositary share | SSaleDisposed | −124 | $164.40F5 | −$20,385.6 | 12,734 | Direct | |
| Apr 20, 2026 | American depositary share | SSaleDisposed | −40 | $165.29F6 | −$6,611.6 | 12,694 | Direct | |
| Apr 20, 2026 | American depositary share | SSaleDisposed | −3 | $166.91 | −$500.73 | 12,691 | Direct | |
| Apr 20, 2026 | American depositary share | SSaleDisposed | −16 | $167.17F7 | −$2,674.72 | 12,675 | Direct | |
| Apr 20, 2026 | American depositary share | SSaleDisposed | −9 | $168.35F8 | −$1,515.15 | 12,666 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average price of shares sold at prices that ranged from $162.01 to $162.97. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of shares sold at prices that ranged from $163.01 to $163.96. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of shares sold at prices that ranged from $164.0125 to $164.90. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average price of shares sold at prices that ranged from $165.03 to $165.66. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average price of shares sold at prices that ranged from $167.06 to $167.26. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents the weighted average price of shares sold at prices that ranged from $168.21 to $168.425. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.